Tumours after kidney transplantation

Current Opinion in Urology

Volumn 13, Issue 2, 2003, Pages 105-109

  Lutz, Jens ^a   Heemann, Uwe ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Follow up; Immunosuppression; Kidney transplantation; Risk factors; Therapy; Tumours

Indexed keywords

BREAST CARCINOMA; CANCER CELL; CANCER INCIDENCE; GASTROINTESTINAL CARCINOMA; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KAPOSI SARCOMA; KIDNEY TRANSPLANTATION; LEUKEMIA; LUNG CARCINOMA; LYMPHOPROLIFERATIVE DISEASE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; REVIEW; SKIN CANCER; TUMOR; UROGENITAL TRACT CANCER; VIRUS INFECTION;

HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISORDERS; NEOPLASMS; SKIN NEOPLASMS; TISSUE DONORS;

EID: 0037337675     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042307-200303000-00004     Document Type: Review

References (30)

1. Birkeland S, Lokkegaard H, Storm H. Cancer risk in patients on dialysis and after renal transplantation. Lancet 2000; 355:1886-1887.
2. Zeier M, Hartschuh W, Wiesel M, et al. Malignancy after renal transplantation. Am J Kidney Dis 2002; 39:1-12. An elegant review on malignancy after kidney transplantation including case reports, data from several European and Australian observations, and discussion of risk factors.
3. Maisonneuve P, Agodoa L, Gellert R, et al. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet 1999; 354:93-99.
4. Sheil A. Cancer in dialysis and transplant patients. In: Kidney transplantation, 5th ed. Morris PJ (editor). Philadelphia: Saunders; 2001. pp. 558-570.
5. Jensen M. Chromosome studies in patients treated with azathioprine. Acta Med Scand 1967; 182:445-455.
6. Hojo M, Morimoto T, Maluccio M, et al. Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature 1999; 397:530-534.
7. Jamil B, Nicholls K, Becket GJ, et al. Impact of acute rejection therapy on infections and malignancies in renal transplant recipients. Transplantation 1999; 68:1597-1603.
8. Luan F, Hojo M, Maluccio M, et al. Rapamycin blocks tumor progression: unlinking immunosuppression from antitumor efficacy. Transplantation 2002; 73:1565-1572. Elegant evidence for the tumour-reducing effects of rapamycin.
9. Cohen J. Epstein-Barr virus infection. N Engl J Med 2000; 343:481-492.
10. Luengrojanakul P, Vareesangthip K, Chainuvati T, et al. Hepatitis C virus infection in patients with chronic liver disease or chronic renal failure and blood donors in Thailand. J Med Virol 1994; 44:287-292.
11. Raengsakulrach B, Ong-aj-yooth L, Thaiprasert T, et al. High prevalence of hepatitis G viremia among kidney transplant patients in Thailand. J Med Virol 1997; 53:162-166.
12. Bouwes Bavinck J, Feltkarmp M, Struijk L, et al. Human papillomavirus infection and skin cancer risk in organ transplant recipients. J Invest Dermatol Symp Proc 2001; 6:207-211. This study analyses the different HPV types in various skin lesions and the possible pathogenetic mechanisms of skin tumour development in graft recipients.
13. Kapelushnik J, Ariad S, Benharroch D, et al. Post renal transplantation human herpesvirus 8-associated lymphoproliferative disorder and Kaposi's sarcoma. Br J Haematol 2001; 113:425-428. An interesting study linking HHV-8 infection with lymphoproliferative disorders and Kaposi's sarcoma showing the involvement in different disorders of this pathogen.
14. Lebbe C. HHV-8 infection in renal transplantation. Nephrologie 2001; 22:313-315.
15. Shell A. Cancer report 1997. In: The twentieth annual report. Australia and New Zealand Dialysis and Transplant Registry; Adelaide, Australia 1997. p. 138.
16. Penn I. Occurrence of cancers in immunosuppressed organ transplant recipients. Clin Transplant 1998; 12:147-158.
17. Davison A. Epidemiology of cancer in patients with renal transplants. Adv Nephrol Necker Hosp 1998; 28:171-194.
18. Berthoux FA, Bradley B, Ekberg H, Frei U. Cancer risk after renal transplantation. Nephrol Dial Transplant 2002; 17 (Suppl. 4):31-35. This article includes the European best guidelines for renal transplantation in the field of malignancy with emphasis on practical approaches in renal transplant patients.
19. Dreno B, Mansat E, Legoux B, et al. Skin cancers in transplant patients. Adv Nephrol Necker Hosp 1997; 27:377-389.
20. McKenna D, Murphy G. Skin cancer chemoprophylaxis in renal transplant recipients: 5 years of experience using low-dose acitretin. Br J Dermatol 1999; 140:656-660.
21. Cockfield S, Preiksaitis J, Jewell L, et al. Post-transplant lymphoproliferative disorder in renal allograft recipients. Clinical experience and risk factor analysis in a single center. Transplantation 1993; 56:88-96.
22. Opelz G, Henderson R. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet 1993; 342:1514-1516.
23. Ellis D, Jaffe R, Green M, et al. Epstein-Barr virus-related disorders in children undergoing renal transplantation with tacrolimus-based immunosuppression. Transplantation 1999; 68:997-1003.
24. Rowe D, Webber S, Schauer E, et al. Epstein-Barr virus load monitoring: its role in the prevention and management of post-transplant lymphoproliferative disease. Transplant Infect Dis 2001; 3:79-87. This study investigates changes in the viral load over time to predict PTLD before symptomatic disease occurs, and to use this in the control of the effectiveness of antiviral therapy in the treatment of PTLD.
25. Shah K. Human papillomaviruses and anogenital cancers. N Engl J Med 1997; 337:1386-1388.
26. Stewart T, Tsai S, Grayson H, et al. Incidence of de-novo breast cancer in women chronically immunosuppressed after organ transplantation. Lancet 1995; 346:796-798.
27. Penn I. Sarcomas in organ allograft recipients. Transplantation 1995; 60:1485-1491.
28. Qunibi W, Akhtar M, Sheth K, et al. Kaposi's sarcoma: the most common tumor after renal transplantation in Saudi Arabia. Am J Med 1988; 84:225-232.
29. Cattani P, Capuano M, Graffeo R, et al. Kaposi's sarcoma associated with previous human herpesvirus 8 infection in kidney transplant recipients. J Clin Microbiol 2001; 39:506-508. This article links the HHV-8 as an aetiological agent to the development of Kaposi's sarcoma in kidney graft recipients.
30. Winter T, Keller P, Lee F, et al. Donor-derived malignancy: transmission of small-cell lung cancer via renal transplantation. J Ultrasound Med 2001; 20:559-562. This article gives an overview about donor-derived malignancy together with a case report.